Title | Type | SJR | H index | Total Docs. (2009) | Total Docs. (3years) | Total Refs. (2009) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2009) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 9.362 Q1 | 247 | 19 | 71 | 6531 | 1541 | 68 | 17.15 | 343.74 | |
2 | Medicinal Research Reviews | journal | 3.062 Q1 | 141 | 27 | 85 | 5423 | 822 | 85 | 9.41 | 200.85 | |
3 | Pharmacology and Therapeutics | journal | 4.101 Q1 | 220 | 103 | 339 | 20152 | 3636 | 338 | 9.97 | 195.65 | |
4 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.487 Q1 | 79 | 12 | 39 | 2263 | 180 | 39 | 4.35 | 188.58 | |
5 | Drug Metabolism Reviews | journal | 1.450 Q1 | 105 | 26 | 113 | 4882 | 573 | 108 | 4.99 | 187.77 | |
6 | Food and Drug Law Journal | journal | 0.282 Q3 | 23 | 32 | 115 | 5476 | 47 | 115 | 0.44 | 171.13 | |
7 | Frontiers in Medicinal Chemistry | book series | 0.226 Q3 | 7 | 29 | 27 | 4600 | 13 | 26 | 0.00 | 158.62 | |
8 | Current Medicinal Chemistry | journal | 1.758 Q1 | 192 | 282 | 767 | 43990 | 4313 | 766 | 5.35 | 155.99 | |
9 | Critical Reviews in Toxicology | journal | 2.075 Q1 | 122 | 38 | 105 | 5576 | 694 | 99 | 4.47 | 146.74 | |
10 | Natural Product Reports | journal | 2.925 Q1 | 200 | 77 | 186 | 11182 | 1455 | 181 | 7.70 | 145.22 | |
11 | Current Drug Metabolism | journal | 1.223 Q1 | 118 | 90 | 255 | 12668 | 1276 | 245 | 4.43 | 140.76 | |
12 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.728 Q1 | 94 | 25 | 69 | 3489 | 351 | 64 | 4.20 | 139.56 | |
13 | Advances in Pharmacology | journal | 1.198 Q1 | 81 | 14 | 73 | 1944 | 220 | 68 | 3.81 | 138.86 | |
14 | Current Molecular Pharmacology | journal | 0.438 Q3 | 46 | 27 | 23 | 3594 | 29 | 23 | 1.26 | 133.11 | |
15 | Current Cancer Drug Targets | journal | 2.329 Q1 | 99 | 75 | 194 | 9712 | 1094 | 185 | 5.44 | 129.49 | |
16 | Recent Patents on CNS Drug Discovery | journal | 0.743 Q2 | 35 | 19 | 70 | 2426 | 195 | 70 | 2.89 | 127.68 | |
17 | Handbook of Experimental Pharmacology | journal | 1.728 Q1 | 103 | 155 | 391 | 19347 | 1315 | 372 | 4.10 | 124.82 | |
18 | Annual Review of Pharmacology and Toxicology | journal | 11.689 Q1 | 218 | 19 | 64 | 2367 | 1528 | 64 | 24.74 | 124.58 | |
19 | Frontiers in Drug Design and Discovery | book series | 0.330 Q2 | 9 | 18 | 41 | 2204 | 31 | 39 | 1.09 | 122.44 | |
20 | Current Gene Therapy | journal | 1.983 Q1 | 78 | 44 | 129 | 5188 | 717 | 126 | 5.83 | 117.91 | |
21 | Advances in Molecular Toxicology | book series | 0.166 Q3 | 17 | 8 | 14 | 942 | 10 | 12 | 0.88 | 117.75 | |
22 | Current Vascular Pharmacology | journal | 1.046 Q2 | 67 | 56 | 109 | 6582 | 355 | 102 | 3.15 | 117.54 | |
23 | Current Pharmaceutical Design | journal | 1.605 Q1 | 176 | 349 | 1097 | 40829 | 4830 | 980 | 4.56 | 116.99 | |
24 | Expert Opinion on Emerging Drugs | journal | 0.863 Q2 | 52 | 45 | 134 | 5224 | 385 | 134 | 3.01 | 116.09 | |
25 | Current Enzyme Inhibition | journal | 0.205 Q4 | 18 | 20 | 74 | 2319 | 44 | 74 | 0.69 | 115.95 | |
26 | Drug Resistance Updates | journal | 3.991 Q1 | 125 | 16 | 52 | 1836 | 571 | 52 | 12.58 | 114.75 | |
27 | Anti-Infective Agents | journal | 0.364 Q3 | 25 | 25 | 77 | 2808 | 83 | 74 | 1.20 | 112.32 | |
28 | Recent Advances in Drug Delivery and Formulation | journal | 38 | 19 | 44 | 2089 | 81 | 44 | 1.84 | 109.95 | ||
29 | Current Neuropharmacology | journal | 1.038 Q2 | 93 | 35 | 81 | 3841 | 198 | 79 | 2.09 | 109.74 | |
30 | Advanced Drug Delivery Reviews | journal | 4.230 Q1 | 348 | 139 | 364 | 15218 | 4432 | 315 | 12.20 | 109.48 | |
31 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.192 Q3 | 26 | 36 | 113 | 3866 | 39 | 101 | 0.23 | 107.39 | |
32 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.628 Q2 | 42 | 30 | 99 | 3163 | 210 | 98 | 2.14 | 105.43 | |
33 | Current Drug Discovery Technologies | journal | 0.553 Q2 | 46 | 27 | 88 | 2842 | 162 | 86 | 1.94 | 105.26 | |
34 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.424 Q1 | 103 | 93 | 182 | 9648 | 834 | 167 | 4.34 | 103.74 | |
35 | Expert Opinion on Drug Discovery | journal | 0.463 Q3 | 77 | 92 | 303 | 9533 | 412 | 296 | 1.42 | 103.62 | |
36 | Expert Opinion on Therapeutic Targets | journal | 1.469 Q1 | 101 | 116 | 345 | 11796 | 1228 | 321 | 3.83 | 101.69 | |
37 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.954 Q2 | 48 | 27 | 72 | 2740 | 246 | 72 | 3.07 | 101.48 | |
38 | Infectious Disorders - Drug Targets | journal | 1.170 Q1 | 59 | 53 | 96 | 5332 | 290 | 86 | 2.78 | 100.60 | |
39 | Current Computer-Aided Drug Design | journal | 0.428 Q3 | 31 | 21 | 82 | 2108 | 135 | 76 | 1.78 | 100.38 | |
40 | Expert Opinion on Drug Delivery | journal | 1.136 Q1 | 126 | 100 | 218 | 9913 | 758 | 204 | 3.20 | 99.13 | |
41 | Mini-Reviews in Medicinal Chemistry | journal | 0.984 Q2 | 101 | 149 | 394 | 14757 | 1314 | 391 | 3.27 | 99.04 | |
42 | Cellular and Molecular Life Sciences | journal | 3.995 Q1 | 248 | 299 | 845 | 28820 | 5683 | 841 | 6.47 | 96.39 | |
43 | Current Drug Targets | journal | 1.775 Q1 | 112 | 131 | 427 | 12582 | 1762 | 379 | 3.86 | 96.05 | |
44 | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | journal | 0.119 Q4 | 28 | 26 | 25 | 2466 | 5 | 25 | 0.20 | 94.85 | |
45 | CNS and Neurological Disorders - Drug Targets | journal | 1.772 Q1 | 93 | 52 | 150 | 4787 | 615 | 134 | 3.85 | 92.06 | |
46 | Topics in Medicinal Chemistry | book series | 14 | 10 | 0 | 913 | 0 | 0 | 0.00 | 91.30 | ||
47 | Current Topics in Medicinal Chemistry | journal | 1.542 Q1 | 127 | 143 | 505 | 12891 | 2038 | 435 | 3.90 | 90.15 | |
48 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.951 Q2 | 95 | 125 | 259 | 11138 | 977 | 253 | 3.58 | 89.10 | |
49 | Issues in Toxicology | book series | 0.197 Q3 | 17 | 18 | 51 | 1596 | 15 | 47 | 0.29 | 88.67 | |
50 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.184 Q3 | 16 | 27 | 125 | 2388 | 47 | 112 | 0.37 | 88.44 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2022. Data Source: Scopus®